- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CRTX
Recent news which mentions CRTX
From Benzinga
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
January 26, 2022
Tickers
CRTX
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 26, 2022
From Benzinga
3 Most-Shorted Stocks at 52-Week Lows to Buy
January 07, 2022
From InvestorPlace
The 10 Most Shorted Stocks Right Now for Friday, Dec. 17
December 17, 2021
From InvestorPlace
2 Short-Squeeze Candidates That Could Go Parabolic Soon
December 09, 2021
From Motley Fool
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard
December 06, 2021
From Benzinga
Could It Finally Be Time To Step Up to The Plate With GME Stock?
November 18, 2021
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
From Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
71 Biggest Movers From Yesterday
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
From Motley Fool
Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors
October 28, 2021
From Motley Fool
64 Biggest Movers From Yesterday
October 28, 2021
From Benzinga
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Cortexyme Shares Plunge
October 27, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 27, 2021
From Benzinga
Mid-Day Market Update: Dow Falls Over 100 Points; Silicon Laboratories Shares Spike Higher
October 27, 2021
From Benzinga
Mid-Morning Market Update: Markets Rise; Coca-Cola Tops Q3 Views
October 27, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021
October 27, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.